Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Pacific Biosciences of California, Inc. on June 18, 2019. The filing details the voting results for director elections and the ratification of the independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to corporate governance voting results.
Material Changes
No material financial changes are reported in this filing. The primary events are the successful election of three Class III directors and the ratification of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It strictly reports the outcomes of shareholder proposals.
Important Facts for Investors
- Director Elections: All three Class III director nominees (David Botstein, Ph.D., William Ericson, and Kathy Ordoñez) were elected with significant majority support.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm.
- Voting Participation: A substantial number of broker non-votes (33,290,234) were recorded for the director elections, indicating shares held by brokers that did not receive voting instructions.
- Term Length: The elected directors will serve until the 2022 annual meeting of stockholders.